Literature DB >> 33989708

Ubiquitin-specific peptidase 22 in cancer.

Tingting Feng1, Sunbin Ling2, Chenyang Xu3, Lisha Ying4, Dan Su5, Xiao Xu6.   

Abstract

Recently, many studies have shown that deubiquitination modification of proteins is of great significance in major physiological processes such as cell proliferation, apoptosis, and differentiation. The ubiquitin-specific peptidase (USP) family is one of the most numerous and structurally diverse of the deubiquitinates known to date. USP22, an important member of the USP family, has been found to be closely associated with tumor cell cycle regulation, stemness maintenance, invasion and metastasis, chemoresistance, and immune regulation. We focus on recent advances regarding USP22's function in cancer and discuss the prospect of USP22 in this review.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Cell cycle regulation; Deubiquitination; Immune microenvironment; Neoplasms; Stemness maintenance

Mesh:

Substances:

Year:  2021        PMID: 33989708     DOI: 10.1016/j.canlet.2021.05.004

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Long Intergenic Noncoding RNA00265 Enhances Cell Viability and Metastasis via Targeting miR-485-5p/USP22 Axis in Osteosarcoma.

Authors:  Ting Chen; Jinxin Liu; He Zhang; Jiatong Li; Guanning Shang
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

Review 2.  Role of ubiquitin specific proteases in the immune microenvironment of prostate cancer: A new direction.

Authors:  Jinhui Guo; Jie Zhao; Litao Sun; Chen Yang
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

Review 3.  Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms.

Authors:  Jinhui Guo; Jie Zhao; Wen Fu; Qiuran Xu; Dongsheng Huang
Journal:  Front Immunol       Date:  2022-07-20       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.